An emerging role for endothelial barrier support therapy for congenital disorders of glycosylation
William Brucker(Providence College), Olaf A. Bodamer(Broad Institute), J. Brian McAlvin(Boston Children's Hospital), Stacy E. Croteau(Boston Children's Hospital), Jeffrey Lo(Boston Children's Hospital), Nidhi Shah(Nassau University Medical Center), Matthew M. Heeney(Boston Children's Hospital), Kate Cullion(Boston Children's Hospital), John R. Prensner(University of Michigan), Gerard T. Berry(Boston Children's Hospital), Christina Yee(Boston Children's Hospital), Katherine R. Peeler(Harvard University)
Cited by 22
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
|Proceedings of the National Academy of Sciences|2007|1.1k
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535